PEA
LLY icon

Park Edge Advisors’s Eli Lilly LLY Stock Holding History

Park Edge Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
1,061
+78
+8% +$79.7K 0.27% 70
2026
Q1 		$904K Sell
983
-238
-19% -$241K 0.21% 74
2025
Q4 		$1.31M Sell
1,221
-530
-30% -$507K 0.3% 70
2025
Q3 		$1.34M Sell
1,751
-185
-10% -$138K 0.31% 63
2025
Q2 		$1.51M Buy
1,936
+179
+10% +$139K 0.39% 51
2025
Q1 		$1.45M Sell
1,757
-367
-17% -$305K 0.4% 46
2024
Q4 		$1.64M Sell
2,124
-154
-7% -$128K 0.48% 45
2024
Q3 		$2.02M Sell
2,278
-178
-7% -$160K 0.58% 31
2024
Q2 		$2.22M Sell
2,456
-107
-4% -$85.6K 0.68% 22
2024
Q1 		$1.99M Buy
2,563
+1,061
+71% +$755K 0.56% 23
2023
Q4 		$876K Buy
1,502
+793
+112% +$463K 0.3% 44
2023
Q3 		$381K Hold
709
– – 0.14% 70
2023
Q2 		$333K Hold
709
– – 0.11% 78
2023
Q1 		$243K Buy
709
+25
+4% +$8.43K 0.09% 87
2022
Q4 		$250K Buy
+684
New +$243K 0.11% 83

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Park Edge Advisors's LLY Position: Q2 2026 in Review

Park Edge Advisors increased its Eli Lilly (LLY) stake by 7.9% in Q2 2026, buying an estimated $79.7K and bringing the position to 1,061 shares worth $1.27M. The position accounts for 0.27% of the portfolio, ranked #70.

Park Edge Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.22M in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park Edge Advisors held 1,061 shares of Eli Lilly worth $1.27M as of Q2 2026.
  • Park Edge Advisors bought 78 Eli Lilly shares in Q2 2026, an estimated $79.7K.
  • Eli Lilly made up 0.27% of Park Edge Advisors's portfolio in Q2 2026, its #70 holding.
  • Park Edge Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Park Edge Advisors's Eli Lilly position peaked at $2.22M in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.